What a price is actually made of
Patients tend to assume an injectable price is mostly product plus greed. The reality is a stack of costs, several of them invisible from the treatment chair, and understanding the stack changes how you read every price list in the sector. It also explains something that otherwise looks like a scandal: the same named treatment, with the same branded product, legitimately selling for £150 in one UK clinic and £450 in another.
This article sets out the stack as it applies to a typical injectable appointment, then applies it to devices and packages. The figures are indicative mid-2026 UK ranges, consistent with the observed market pricing in our UK cost review, and they are deliberately broad, because clinic cost bases genuinely differ.
The cost stack, line by line
| Cost line | Indicative range per toxin appointment | Notes |
|---|---|---|
| Product | £25, £75 | Genuine branded toxin, dose-dependent; filler £60, £180 per ml wholesale |
| Practitioner time | £40, £150 | Consultation, treatment, notes, review; varies with qualification and appointment length |
| Prescriber fee | £0, £50 | Where the injector does not prescribe, a prescriber consults and charges per patient |
| Insurance | £5, £25 | Medical indemnity apportioned per appointment; higher for higher-risk procedures |
| Premises and staff | £20, £90 | Rent, reception, clinical waste, sterilisation, software, utilities; the big London variable |
| Equipment and training | £5, £40 | Device amortisation where relevant, ongoing CPD, complication training |
| Marketing and acquisition | £10, £60 | A real cost per new patient that patients indirectly fund |
Stack the middles of those ranges and a defensible break-even for a properly run toxin appointment sits somewhere between £150 and £250 before any profit at all. That single arithmetic fact is the most useful consumer lens in this article: it defines the floor below which something in the stack must have been removed.
Why identical treatments vary threefold
Four variables do most of the work, and only one of them is clinical.
Location. Premises and staff costs in central London run multiples of regional equivalents, and the 40 to 70 per cent London premium observed across the market is mostly this line moving. The product in the syringe is identical in Mayfair and Manchester.
Time. A thirty-minute appointment and a ninety-minute appointment can carry the same treatment name. Longer appointments buy assessment, discussion and unhurried technique, and they cost the clinic real money, because appointment slots are the clinic's inventory. This is the price difference most worth paying for.
Qualification and prescribing model. A doctor- or nurse-prescriber-led clinic carries higher salary costs and higher indemnity than an injector-plus-remote-prescriber model, and prices reflect it. Note the direction of the incentive: the cheaper model is the one professional guidance criticises, for reasons set out in our consultation red flags checklist.
Positioning. Beyond the cost stack sits brand: interior design, prestige postcode, waiting-list signalling. Some of what premium clinics charge is simply positioning margin, and patients should recognise it as such. Positioning is not fraud, but it is not clinical quality either, and the sector's drift toward brand-led, systematised business models, examined in our piece on clinics built like tech companies, is widening this layer of the price.
What cheap actually cuts
A price materially below the break-even floor is not a bargain, it is a question, and the realistic answers available to it are limited. Something in the stack has been cut, and the candidates are these.
- Product. Diluted toxin, fewer units than quoted, cheaper or parallel-imported filler, or in the worst cases product that is not what it claims. The MHRA has repeatedly warned about unlicensed and counterfeit product circulating in the sector, and price is the main channel through which it reaches patients via the MHRA's enforcement casework.
- Time. High-volume models book injectable appointments in fifteen-minute slots. Assessment, consent and aftercare compress to fit.
- Qualification. The cheapest labour in the sector is the least qualified, and for filler, the law currently permits it, as we set out in our explainer on what aesthetic clinic means in UK law.
- Insurance. Practising underinsured or uninsured removes a real cost line, and the patient discovers it only when making a claim against someone with nothing to claim against.
- Complication readiness. Hyaluronidase stock, emergency protocols and complication training are pure cost until the day they are everything.
A price below the cost of doing the job properly is not a discount. It is a disclosure.
None of this means every low price hides malpractice. A new practitioner building a caseload, a regional cost base, or a clinic running genuinely lean can all price low for defensible reasons. But below a certain floor the arithmetic stops working, and the patient is entitled to ask which line was cut, and to expect a specific answer.
Why expensive is not automatically better
The inverse error deserves equal time. Above the level that funds a properly resourced appointment, additional price buys positioning faster than it buys safety. Complaint data from accreditation bodies such as Save Face includes prestige clinics as well as bargain ones, and a high price funds marble as readily as it funds medicine. The variables that predict outcomes, practitioner skill, time, product, complication readiness, are all verifiable directly, and verifying them is more informative than reading the price as a proxy in either direction. Price tells you about the business. The consultation tells you about the medicine.
How to read a price list like an insider
- Check the unit. Per area, per ml, per session, per course. Undefined areas and part-ml pricing make comparison impossible, which is sometimes the point.
- Ask what the price includes. Consultation, review appointment, top-up policy, and whether a prescriber consultation is included or extra.
- Apply the floor test. A toxin price well under £150, or filler well under £200 per ml in a full-service clinic, means something in the stack is missing. Ask what.
- Treat packages as commitments, not savings. Prepaid courses lock you in before you have seen how you respond to one session.
- Weigh time as part of the price. A £300 appointment lasting an hour with a prescriber may be better value than a £180 slot lasting fifteen minutes with neither.
- Spend the difference on verification. Registers and accreditation checks are free, and they predict outcomes better than any price point does.
The mature conclusion for patients is unglamorous: price is information, not judgement. Read the stack behind it, and it tells you how a clinic values the parts of the job you cannot see. Those parts are the ones that matter.
